Global Plasma Protease C1-inhibitor Treatment Market Analysis 2013-2018 and Forecast 2019-2024

Region:Global

Author(s):

Product Code:99SGL298Lif2019000022251

Download Sample Report download
Buy the Full ReportStarting from $2980
Published on

May 2019

Total pages

84

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $2980

About the Report

About the Report

Snapshot

The global Plasma Protease C1-inhibitor Treatment market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Plasma Protease C1-inhibitor Treatment by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

By Drug Class

C1-inhibitors

Kallikrein Inhibitor (Kalbitor)

Selective Bradykinin B2 Receptor Antagonist (Firazyr)

By Dosage Type

Liquid/Injectable

Lyophilized

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Shire plc

CSL Limited

Sanquin

Pharming Group N.V.

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Hospital Pharmacies

Independent Pharmacies and Outlets

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Products

Table of Contents

Table of Contents

Table of Contents

1 Industry Overview

1.1 Plasma Protease C1-inhibitor Treatment Industry

1.1.1 Overview

1.1.2 Development of Plasma Protease C1-inhibitor Treatment

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Plasma Protease C1-inhibitor Treatment Market by Drug Class

3.1 By Drug Class

3.1.1 C1-inhibitors

3.1.2 Kallikrein Inhibitor (Kalbitor)

3.1.3 Selective Bradykinin B2 Receptor Antagonist (Firazyr)

3.2 By Dosage Type

3.3 Market Size

3.4 Market Forecast

4 Major Companies List

4.Plasma Protease C1-inhibitor Treatment Shire plc (Company Profile, Sales Data etc.)

4.2 CSL Limited (Company Profile, Sales Data etc.)

4.3 Sanquin (Company Profile, Sales Data etc.)

4.4 Pharming Group N.V. (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Hospital Pharmacies

6.1.2 Demand in Independent Pharmacies and Outlets

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List of Figure

Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2013-2018, by Drug Class, in USD Million

Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2013-2018, by Drug Class, in Volume

Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2013-2018, by Dosage Type, in USD Million

Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2013-2018, by Dosage Type, in Volume

Figure North America Plasma Protease C1-inhibitor Treatment Market Concentration, in 2018

Figure Europe Plasma Protease C1-inhibitor Treatment Market Market Concentration, in 2018

Figure Asia-Pacific Plasma Protease C1-inhibitor Treatment MMarket Concentration, in 2018

Figure South America Plasma Protease C1-inhibitor Treatment Market Concentration, in 2018

Figure Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Concentration, in 2018

Figure Plasma Protease C1-inhibitor Treatment Demand in Hospital Pharmacies, 2013-2018, in USD Million

Figure Plasma Protease C1-inhibitor Treatment Demand in Hospital Pharmacies, 2013-2018, in Volume

Figure Plasma Protease C1-inhibitor Treatment Demand in Independent Pharmacies and Outlets, 2013-2018, in USD Million

Figure Plasma Protease C1-inhibitor Treatment Demand in Independent Pharmacies and Outlets, 2013-2018, in Volume

Figure North America Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in USD Million

Figure North America Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in Volume

Figure Europe Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in USD Million

Figure Europe Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in Volume

Figure South America Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in USD Million

Figure South America Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview


List of Table

Table Upstream Segment of Plasma Protease C1-inhibitor Treatment

Table Application Segment of Plasma Protease C1-inhibitor Treatment

Table Global Plasma Protease C1-inhibitor Treatment Market 2013-2024, by Application, in USD Million

Table Major Company List of C1-inhibitors

Table Major Company List of Kallikrein Inhibitor (Kalbitor)

Table Major Company List of Selective Bradykinin B2 Receptor Antagonist (Firazyr)

Table Major Company List of Liquid/Injectable

Table Major Company List of Lyophilized

Table Global Plasma Protease C1-inhibitor Treatment Market 2013-2018, by Drug Class, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Market 2013-2018, by Drug Class, in Volume

Table Global Plasma Protease C1-inhibitor Treatment Market 2013-2018, by Dosage Type, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Market 2013-2018, by Dosage Type, in Volume

Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2024, by Drug Class, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2024, by Drug Class, in Volume

Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2024, by Dosage Type, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2024, by Dosage Type, in Volume

Table Shire plc Overview List

Table Plasma Protease C1-inhibitor Treatment Business Operation of Shire plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CSL Limited Overview List

Table Plasma Protease C1-inhibitor Treatment Business Operation of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanquin Overview List

Table Plasma Protease C1-inhibitor Treatment Business Operation of Sanquin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pharming Group N.V. Overview List

Table Plasma Protease C1-inhibitor Treatment Business Operation of Pharming Group N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Plasma Protease C1-inhibitor Treatment Sales Revenue 2013-2018, by Company, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Sales Revenue Share, by Company, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Sales Volume 2013-2018, by Company, in Volume

Table Global Plasma Protease C1-inhibitor Treatment Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Plasma Protease C1-inhibitor Treatment Demand Forecast 2019-2024, by Application, in USD Million

Table Plasma Protease C1-inhibitor Treatment Demand Forecast 2019-2024, by Application, in Volume

Table Plasma Protease C1-inhibitor Treatment Production 2013-2018, by Region, in USD Million

Table Plasma Protease C1-inhibitor Treatment Production 2013-2018, by Region, in Volume

Table Global Plasma Protease C1-inhibitor Treatment Market 2013-2018, by Region, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Market Share 2013-2018, by Region, in USD Million

Table Global Plasma Protease C1-inhibitor Treatment Market 2013-2018, by Region, in Volume

Table Global Plasma Protease C1-inhibitor Treatment Market Share 2013-2018, by Region, in Volume

Table North America Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in USD Million

Table North America Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in Volume

Table Europe Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in USD Million

Table Europe Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in Volume

Table South America Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in USD Million

Table South America Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size 2013-2018, by Country, in Volume

Table Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2024, by Region, in USD Million

Table Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022